NO307177B1 - Kinolon-derivat for behandling av urin-inkontinens, anvendelse derav, fremgangsmåte for fremstilling og farmasoeytisk blanding - Google Patents

Kinolon-derivat for behandling av urin-inkontinens, anvendelse derav, fremgangsmåte for fremstilling og farmasoeytisk blanding

Info

Publication number
NO307177B1
NO307177B1 NO964345A NO964345A NO307177B1 NO 307177 B1 NO307177 B1 NO 307177B1 NO 964345 A NO964345 A NO 964345A NO 964345 A NO964345 A NO 964345A NO 307177 B1 NO307177 B1 NO 307177B1
Authority
NO
Norway
Prior art keywords
preparation
urinary incontinence
treatment
pharmaceutical composition
quinolone derivative
Prior art date
Application number
NO964345A
Other languages
English (en)
Norwegian (no)
Other versions
NO964345L (no
NO964345D0 (no
Inventor
JOHN EDWARD c WARAWA
Jr Cyrus John Ohnmacht
Diane Amy Trainor
James Michael Hulsizer
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO964345D0 publication Critical patent/NO964345D0/no
Publication of NO964345L publication Critical patent/NO964345L/no
Publication of NO307177B1 publication Critical patent/NO307177B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO964345A 1994-04-14 1996-10-11 Kinolon-derivat for behandling av urin-inkontinens, anvendelse derav, fremgangsmåte for fremstilling og farmasoeytisk blanding NO307177B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407432A GB9407432D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivative
PCT/GB1995/000845 WO1995028388A1 (fr) 1994-04-14 1995-04-13 Derive de quinolone utilise dans le traitement de l'incontinence urinaire

Publications (3)

Publication Number Publication Date
NO964345D0 NO964345D0 (no) 1996-10-11
NO964345L NO964345L (no) 1996-12-11
NO307177B1 true NO307177B1 (no) 2000-02-21

Family

ID=10753541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964345A NO307177B1 (no) 1994-04-14 1996-10-11 Kinolon-derivat for behandling av urin-inkontinens, anvendelse derav, fremgangsmåte for fremstilling og farmasoeytisk blanding

Country Status (24)

Country Link
EP (1) EP0755382B1 (fr)
JP (1) JP3782445B2 (fr)
KR (1) KR100344885B1 (fr)
CN (1) CN1058708C (fr)
AT (1) ATE202089T1 (fr)
AU (1) AU700773B2 (fr)
BR (1) BR9507366A (fr)
CA (1) CA2187525C (fr)
CZ (1) CZ284652B6 (fr)
DE (1) DE69521310T2 (fr)
DK (1) DK0755382T3 (fr)
ES (1) ES2159633T3 (fr)
FI (2) FI114705B (fr)
GB (1) GB9407432D0 (fr)
GR (1) GR3036482T3 (fr)
HU (1) HU215387B (fr)
MX (1) MX9603920A (fr)
NO (1) NO307177B1 (fr)
NZ (1) NZ283779A (fr)
PL (2) PL183095B1 (fr)
PT (1) PT755382E (fr)
RU (1) RU2149870C1 (fr)
SK (1) SK281124B6 (fr)
WO (1) WO1995028388A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02001207A (es) * 1999-08-03 2002-07-30 Abbott Lab Abridores de canal de potasio.
AU2001282744A1 (en) * 2000-08-02 2002-02-13 Astrazeneca Ab Process for asymmetric synthesis of substituted 1,4-dihydropyridines
SE0200205D0 (sv) * 2002-01-24 2002-01-24 Astrazeneca Ab Method
UA92009C2 (ru) * 2005-05-04 2010-09-27 Н.В. Органон Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия
UA92008C2 (en) * 2005-05-04 2010-09-27 Н.В. Органон 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
SU435237A1 (ru) * 1972-08-08 1974-07-05 Ордена Трудового Красного Знамени институт химических наук Способ получения производных 5-кето-5,6,7,8-тетрагидрохинолина
GB1432379A (en) * 1973-07-12 1976-04-14 Wyeth John & Brother Ltd Preparation of quinoline derivatives
GB1465651A (en) * 1974-04-19 1977-02-23 Wyeth John & Brother Ltd Carbocyclic-fused ring pyridine derivatives
GB9220570D0 (en) * 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
MX9603920A (es) 1997-04-30
RU2149870C1 (ru) 2000-05-27
PL182031B1 (pl) 2001-10-31
KR100344885B1 (ko) 2002-11-30
CA2187525A1 (fr) 1995-10-26
HUT76132A (en) 1997-06-30
GB9407432D0 (en) 1994-06-08
CN1058708C (zh) 2000-11-22
ES2159633T3 (es) 2001-10-16
DE69521310D1 (de) 2001-07-19
JP3782445B2 (ja) 2006-06-07
FI114705B (fi) 2004-12-15
HK1013999A1 (en) 1999-09-17
NO964345L (no) 1996-12-11
NO964345D0 (no) 1996-10-11
BR9507366A (pt) 1997-09-23
HU215387B (hu) 1998-12-28
GR3036482T3 (en) 2001-11-30
CZ284652B6 (cs) 1999-01-13
CN1146202A (zh) 1997-03-26
JPH09512254A (ja) 1997-12-09
CA2187525C (fr) 2006-01-24
WO1995028388A1 (fr) 1995-10-26
ATE202089T1 (de) 2001-06-15
NZ283779A (en) 1998-02-26
AU2219995A (en) 1995-11-10
PT755382E (pt) 2001-11-30
DK0755382T3 (da) 2001-09-10
FI20040352L (fi) 2004-03-04
PL183095B1 (pl) 2002-05-31
PL316790A1 (en) 1997-02-17
CZ298196A3 (en) 1997-02-12
FI964019A0 (fi) 1996-10-07
FI115630B (fi) 2005-06-15
SK281124B6 (sk) 2000-12-11
HU9602747D0 (en) 1996-11-28
FI964019L (fi) 1996-10-07
AU700773B2 (en) 1999-01-14
EP0755382A1 (fr) 1997-01-29
SK131796A3 (en) 1997-05-07
EP0755382B1 (fr) 2001-06-13
DE69521310T2 (de) 2002-04-18

Similar Documents

Publication Publication Date Title
AU6027996A (en) Substituted sulfonylphenylheterocycles as cyclooxygenase-2 a nd 5-lipoxygenase inhibitors
EP1407768A3 (fr) L'agoniste des canaux potassiques retigabine pour le traitement de maladies
FR12C0004I1 (fr)
FI970859A7 (fi) Metallien käsittelykoostumus ja -prosessi
EP1007556A4 (fr) Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
FI102177B1 (fi) Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet
CA2157142A1 (fr) Traitement des maladies causees par les desordres de la glande sebacee
DE69613386D1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
AU628197B2 (en) Agent for the treatment of cast iron melts, process for the production thereof and the use thereof for treating cast iron melts
NO964345D0 (no) Kinolon-derivat for behandling av urin-inkontinens
AU5220990A (en) Phytosanitary composition, its process of preparation and its use for treating cryptogamic diseases
AU6252699A (en) Composition and method for treating allergic diseases
MA26648A1 (fr) Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation.
WO2002020031A3 (fr) Procede de traitement de la schizophrenie et des psychoses apparentees, et utilisation de l'erythropoietine ou des derives de l'erythropoietine pour le traitement des schizophrenies et psychoses apparentees
AU4882897A (en) Disinfectant composition, particularly for the prevention of dermatitis induced by diapers, and method for its use
AU6391199A (en) Composition and method for treating allergic diseases
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
FR2763933B1 (fr) Procede de preparation de zircons par traitement hydrothermique et zircons ainsi obtenus
FR2720011B1 (fr) Composition pour le traitement des fruits et légumes par thermonébulisation, et procédé de traitement.
AUPN904796A0 (en) Method and composition for treatment of ocular diseases
HU9500131D0 (en) Apparatus for treatment of livingcreatures, above all humans and process for its production
HK1034675A (en) Composition and method for treating allergic diseases
HK1034670A (en) Composition and method for treating allergic diseases
AUPN616195A0 (en) Method and composition for treatment of ocular diseases
AU3974597A (en) Composition, process and method for treating grass by foliar application

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees